# HPC Offered for PRESERVE Expansion

> **NCT07145411** · — · RECRUITING · sponsor: **Ossium Health, Inc.** · enrollment: 10 (estimated)

## Conditions studied

- Bone Marrow Transplant (BMT)

## Interventions

- **OTHER:** Bone Marrow Transplant with Ossium's HPC, Marrow (bone marrow recovered from deceased organ and tissue donors)

## Key facts

- **NCT ID:** NCT07145411
- **Lead sponsor:** Ossium Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-27
- **Primary completion:** 2027-08
- **Final completion:** 2029-08
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145411, "HPC Offered for PRESERVE Expansion". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07145411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*